Avidity Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2024 | 1 | -$0.76 | -$0.76 | -$0.76 |
| Q3 2024 | 2 | -$0.71 | -$0.71 | -$0.71 |
| Q4 2024 | 6 | -$1.09 | -$0.24 | -$0.75 |
| Q1 2025 | 4 | -$0.87 | -$0.59 | -$0.74 |
| Q2 2025 | 2 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2025 | 2 | -$0.80 | -$0.80 | -$0.80 |
| Q4 2025 | 2 | -$0.82 | -$0.82 | -$0.82 |
| Q1 2026 | 1 | -$0.84 | -$0.84 | -$0.84 |
| Q2 2026 | 1 | -$0.84 | -$0.84 | -$0.84 |
| Q3 2026 | 1 | -$0.87 | -$0.87 | -$0.87 |
| Q4 2026 | 1 | -$0.87 | -$0.87 | -$0.87 |
Avidity Biosciences, Inc. Earnings Date And Information
Avidity Biosciences, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.65 earnings per share for the quarter, topping analysts' consensus estimates of $-0.71 by $0.06. The company had revenue of 2.34 M for the quarter and had revenue of 9.56 M for the year. Avidity Biosciences, Inc. has generated $-3 earnings per share over the last year ($-2.91 diluted earnings per share) and currently has a price-to-earnings ratio of -19.02. Avidity Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Avidity Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.65 | $4.07 M | $2.34 M | ||
| 08/09/2024 | Q2 2024 | -$0.76 | -$0.66 | 0.1 | $2.63 M | $2.05 M |
| 05/09/2024 | Q1 2024 | -$0.81 | -$0.79 | 0.02 | $3.54 M | |
| 02/28/2024 | Q4 2023 | -$0.54 | -$0.79 | -0.25 | $2.19 M | |
| 11/08/2023 | Q3 2023 | -$0.76 | -$0.71 | 0.05 | $2.21 M | $2.82 M |
| 08/08/2023 | Q2 2023 | -$0.84 | -$0.66 | 0.18 | $2.14 M | $2.32 M |
| 05/09/2023 | Q1 2023 | -$0.90 | -$0.67 | 0.23 | $2.23 M | |
| 02/28/2023 | Q4 2022 | -$0.84 | -$0.83 | 0.01 | $2.77 M | |
| 11/08/2022 | Q3 2022 | -$0.97 | -$0.80 | 0.17 | $2.13 M | $2.48 M |
| 08/09/2022 | Q2 2022 | -$0.74 | -$0.92 | -0.18 | $2.11 M | $2.18 M |
| 05/10/2022 | Q1 2022 | -$0.94 | -$0.71 | 0.23 | $1.80 M | |
| 03/01/2022 | Q4 2021 | -$0.73 | -$1.63 | -0.9 | $1.85 M | |
| 11/09/2021 | Q3 2021 | -$0.63 | -$0.68 | -0.05 | $2.13 M | $2.16 M |
| 08/09/2021 | Q2 2021 | -$0.77 | -$0.70 | 0.07 | $1.94 M | $2.61 M |
| 05/12/2021 | Q1 2021 | -$0.52 | -$0.64 | -0.12 | $2.70 M | |
| 03/15/2021 | Q4 2020 | -$0.34 | -$0.43 | -0.09 | $2.14 M | |
| 11/10/2020 | Q3 2020 | -$0.32 | -$0.31 | 0.01 | $575,000 | $1.75 M |
| 08/11/2020 | Q2 2020 | -$1.23 | $700,000 | $1.54 M | ||
| 03/30/2020 | Q1 2020 | -$0.20 | $1.36 M | |||
| 12/30/2019 | Q4 2019 | -$0.50 | $1.45 M |
Avidity Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Avidity Biosciences, Inc.'s earnings date?
Avidity Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Avidity Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Avidity Biosciences, Inc. (:RNA) reported $-0.65 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.71 by $0.06.
-
How can I listen to Avidity Biosciences, Inc.'s earnings conference call?
The conference call for Avidity Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Avidity Biosciences, Inc.'s conference call transcript?
The conference call transcript for Avidity Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Avidity Biosciences, Inc. generate each year?
Avidity Biosciences, Inc. (:RNA) has a recorded annual revenue of $9.56 M.
-
How much profit does Avidity Biosciences, Inc. generate each year?
Avidity Biosciences, Inc. (:RNA) has a recorded net income of $9.56 M. Avidity Biosciences, Inc. has generated $-2.91 earnings per share over the last four quarters.
-
What is Avidity Biosciences, Inc.'s price-to-earnings ratio?
Avidity Biosciences, Inc. (:RNA) has a price-to-earnings ratio of -19.02 and price/earnings-to-growth ratio is -9.35.
